Início › Câncer de Pulmão › Kansas

Ensaios clínicos de Câncer de Pulmão em Kansas

21 estudos para Câncer de Pulmão estão buscando participantes em locais em Kansas.

Cidades em Kansas

Texto oficial do estudo (Inglês)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

The University of Kansas Cancer Center - Olathe, Olathe
Cancer Center of Kansas - Pratt, Pratt
Cancer Center of Kansas-Wichita Medical Arts Tower, Wichita
e mais 2

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04267848

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Central Care Cancer Center - Garden City, Garden City
Central Care Cancer Center - Great Bend, Great Bend
Veteran Administration Eastern Kansas Healthcare, Leavenworth
e mais 4

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Cancer Center of Kansas-Wichita Medical Arts Tower, Wichita
Ascension Via Christi Hospitals Wichita, Wichita
Cancer Center of Kansas - Wichita, Wichita

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT04181060

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

HaysMed, Hays
Lawrence Memorial Hospital, Lawrence
The University of Kansas Cancer Center - Olathe, Olathe
e mais 2

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06498635

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

The University of Kansas Cancer Center, Westwood

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT06881784

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Saint Luke's South Hospital, Overland Park

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06758401

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

University of Kansas Clinical Research Center, Fairway
University of Kansas Cancer Center, Kansas City
University of Kansas Hospital-Indian Creek Campus, Overland Park
e mais 1

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT06287775

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

The University of Kansas Cancer Center - Westwood, Westwood

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT06119581

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

University of Kansas Medical Center, Kansas City

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT06343402

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

University of Kansas Cancer Center, Kansas City
University of Kansas Cancer Center-Overland Park, Overland Park

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT06500481

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

University of Kansas Cancer Center, Kansas City
Lawrence Memorial Hospital, Lawrence
The University of Kansas Cancer Center - Olathe, Olathe
e mais 5

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT05624996

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

The University of Kansas Cancer Center, Kansas City

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 11 de ago. de 2026 · NCT05592626

Integrated Cancer Repository for Cancer Research

Saint Luke's Cancer Instititute - South, Overland Park

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades de 19 a 110 · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT02012699

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

The University of Kansas Cancer Center, Westwood

RecrutandoFase 1/2

Idades de 18 a 70 · Todos os sexos · Atualizado em 11 de jun. de 2026 · NCT05361174

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

University of Kansas Clinical Research Center, Fairway
HaysMed, Hays
University of Kansas Cancer Center, Kansas City
e mais 7

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 3 de jun. de 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

University of Kansas Clinical Research Center, Fairway
HaysMed, Hays
University of Kansas Cancer Center, Kansas City
e mais 7

RecrutandoFase 2

18 Minutes · Todos os sexos · Atualizado em 5 de mai. de 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

University of Kansas Clinical Research Center, Fairway
HaysMed, Hays
University of Kansas Cancer Center, Kansas City
e mais 8

RecrutandoFase 2/3

Idades 18 e acima · Todos os sexos · Atualizado em 5 de mai. de 2026 · NCT06616584

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

The University of Kansas Cancer Center, Fairway

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 18 de mar. de 2026 · NCT06244771

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Aton Health, Leawood
Ascension Via Christi Wichita, Wichita

RecrutandoEstudo observacional

Idades 50 e acima · Todos os sexos · Atualizado em 5 de ago. de 2025 · NCT06122077

Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier

University of Kansas Medical Center, Kansas City

RecrutandoEstudo observacional

Idades de 29 a 85 · Todos os sexos · Atualizado em 13 de nov. de 2024 · NCT06426628

Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC

The University of Kansas Cancer Center (KUCC), Fairway
The University of Kansas Cancer Center, Westwood Campus, Kansas City

RecrutandoEstudo observacional

Idades de 18 a 110 · Todos os sexos · Atualizado em 23 de fev. de 2024 · NCT05332925

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.